1
|
Shirakuni Y, Okamoto K, Uejima E, Inui S, Takahara JI, Ohgaru T, Yamasaki H, Tian Y, Kawashita N, Inoue R, Yasunaga T, Takagi T. A Practical Estimation Method for Analyzing Adverse Drug Reactions Using Data Mining. Ther Innov Regul Sci 2013; 47:235-241. [PMID: 30227520 DOI: 10.1177/0092861512460759] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
This study aimed to determine the potentially severe chemical properties of drugs that can cause adverse drug reactions (ADRs) such as erythema multiforme (EM), Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN) by using a data mining method. The study data were extracted from the Adverse Event Reporting System database of the FDA. EM was considered a mild reaction, and SJS and TEN were considered severe reactions. In this study, a new concept termed the "risk of aggravation" (ROA) was defined as whether a certain drug is more likely to cause severe adverse reactions than mild ones. Partial least squares and logistic regression analysis were applied using binary response variable ROAs. These analyses correctly predicted 50 of the 72 drugs associated with SJS and/or TEN and 28 of the 38 drugs associated with EM using binary chemical descriptors that are the same as those using the metric chemical descriptors.
Collapse
Affiliation(s)
- Yuko Shirakuni
- 1 Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan
| | - Kousuke Okamoto
- 1 Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan
| | - Etuko Uejima
- 1 Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.,2 Department of Hospital Pharmacy Education, Osaka University, Osaka, Japan
| | - Shigeki Inui
- 3 Department of Skin and Hair Regenerative Medicine, Osaka University School of Medicine, Osaka, Japan.,4 Department of Dermatology, Osaka University Hospital, Osaka, Japan
| | - Jun-Ichi Takahara
- 1 Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan
| | - Takanori Ohgaru
- 1 Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.,6 Medicinal Chemistry Research Laboratories I, Mitsubishi Tanabe Pharma Corp, Osaka, Japan
| | - Hiroyuki Yamasaki
- 1 Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.,7 Kitasato University School of Pharmacy, Tokyo, Japan
| | - Yushi Tian
- 1 Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan
| | - Norihito Kawashita
- 1 Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.,5 Genome Information Research Center, Institute for Microbial Diseases, Osaka University, Osaka, Japan
| | - Ran Inoue
- 1 Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan
| | - Teruo Yasunaga
- 5 Genome Information Research Center, Institute for Microbial Diseases, Osaka University, Osaka, Japan
| | - Tatsuya Takagi
- 1 Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.,5 Genome Information Research Center, Institute for Microbial Diseases, Osaka University, Osaka, Japan
| |
Collapse
|